Literature DB >> 31414221

Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.

Yong Bae Ji1, Chang Myeon Song1, Donghwan Kim1, Eui-Suk Sung2, Dong Won Lee3, Min Sung Chung4, Kyung Tae5.   

Abstract

PURPOSE: This study aimed to compare the oncologic outcomes of hemithyroidectomy with total thyroidectomy in clinically node-negative (cN0) papillary thyroid carcinoma (PTC) with minimal extrathyroidal extension (ETE).
METHODS: Among 1826 PTC patients who underwent thyroidectomy from Jan 2001 to Dec 2014, there were 255 with unilateral cN0 PTC with minimal ETE and of equal to or less than 2 cm in size; these 255 patients were included in this study. We excluded patients who had tumor size > 2 cm, bilateral tumors, clinically positive nodes, maximal or no ETE, gross invasion of sternothyroid muscle, recurrent cancers or distant metastases. Total thyroidectomy was performed in 173 of the 255 patients, and hemithyroidectomy in 82 of them. A propensity score-matched analysis was carried out to reduce selection bias, with the following covariates: sex, age, tumor size, multiplicity and central neck dissection.
RESULTS: In the baseline data of the 255 patients, female, age and tumor size were significantly higher in the total thyroidectomy group as was Stage III, whereas T and N classification did not differ in the two groups. Propensity score matching generated two matched groups of 66 patients each, in which the significant differences between the two groups seen in the baseline analysis disappeared. In the matched samples, recurrence rate (3.0% vs. 1.5%, p = 1.0) and recurrence-free survival curves did not differ between total thyroidectomy and hemithyroidectomy.
CONCLUSIONS: Hemithyroidectomy can be recommended for cN0 PTC 1 cm or less with minimal ETE. Also it can be considered for cN0 PTC 11-20 mm with minimal ETE.

Entities:  

Keywords:  Extrathyroidal extension; Hemithyroidectomy; Papillary thyroid carcinoma; Propensity score matching; Recurrence

Mesh:

Year:  2019        PMID: 31414221     DOI: 10.1007/s00405-019-05598-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.

Authors:  Song Jae Lee; Chang Myeon Song; Yong Bae Ji; Yun Young Choi; Young Seok Sohn; Jung Hwan Park; Dong Sun Kim; Kyung Tae
Journal:  Langenbecks Arch Surg       Date:  2021-05-10       Impact factor: 3.445

Review 2.  [Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Authors:  H Dralle; F Weber; A Machens; T Brandenburg; K W Schmid; D Führer-Sakel
Journal:  Chirurgie (Heidelb)       Date:  2022-09-19

Review 3.  Hemithyroidectomy versus total thyroidectomy for well differentiated T1-2 N0 thyroid cancer: systematic review and meta-analysis.

Authors:  P M Rodriguez Schaap; M Botti; R H J Otten; K M A Dreijerink; E J M Nieveen van Dijkum; H J Bonjer; A F Engelsman; C Dickhoff
Journal:  BJS Open       Date:  2020-10-06

4.  Thyroid lobectomy is sufficient for differentiated thyroid cancer with upgraded risk after surgery.

Authors:  Soon Min Choi; Dong Gyu Kim; Ji-Eun Lee; Joon Ho; Jin Kyong Kim; Cho Rok Lee; Sang-Wook Kang; Jandee Lee; Jong Ju Jeong; Woong Youn Chung; Kee-Hyun Nam
Journal:  Gland Surg       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.